Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Masayuki Fukata

Showing results (41-50 of 47) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 47 results.
American Journal of Physiology. Gastrointestinal and Liver Physiology|April 11, 2009
A novel Toll-like receptor 4 antagonist antibody ameliorates inflammation but impairs mucosal healing in murine colitisRyan Ungaro, Masayuki Fukata, David Hsu, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|May 26, 2010
Toll-like receptor 4 differentially regulates epidermal growth factor-related growth factors in response to intestinal mucosal injuryDavid Hsu, Masayuki Fukata, Yasmin G Hernandez, et al.
Journal of Innate Immunity|August 30, 2014
Human intestinal epithelial cells express interleukin-10 through Toll-like receptor 4-mediated epithelial-macrophage crosstalkJinhee Hyun, Laura Romero, Reldy Riveron, et al.
Gastroenterology|December 7, 2007
Toll-like receptor-4 promotes the development of colitis-associated colorectal tumorsMasayuki Fukata, Anli Chen, Arunan S Vamadevan, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 29, 2017
Myeloid ATG16L1 Facilitates Host-Bacteria Interactions in Maintaining Intestinal HomeostasisHong Zhang, Libo Zheng, Dermot P B McGovern, et al.
Inflammatory Bowel Diseases|June 16, 2011
Constitutive activation of epithelial TLR4 augments inflammatory responses to mucosal injury and drives colitis-associated tumorigenesisMasayuki Fukata, Limin Shang, Rebeca Santaolalla, et al.
Plos One|May 22, 2013
TLR4 activates the β-catenin pathway to cause intestinal neoplasiaRebeca Santaolalla, Daniel A Sussman, Jose R Ruiz, et al.
Pageof 5

Showing results (41-50 of 47) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 47 results.
American Journal of Physiology. Gastrointestinal and Liver Physiology|April 11, 2009
A novel Toll-like receptor 4 antagonist antibody ameliorates inflammation but impairs mucosal healing in murine colitisRyan Ungaro, Masayuki Fukata, David Hsu, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|May 26, 2010
Toll-like receptor 4 differentially regulates epidermal growth factor-related growth factors in response to intestinal mucosal injuryDavid Hsu, Masayuki Fukata, Yasmin G Hernandez, et al.
Journal of Innate Immunity|August 30, 2014
Human intestinal epithelial cells express interleukin-10 through Toll-like receptor 4-mediated epithelial-macrophage crosstalkJinhee Hyun, Laura Romero, Reldy Riveron, et al.
Gastroenterology|December 7, 2007
Toll-like receptor-4 promotes the development of colitis-associated colorectal tumorsMasayuki Fukata, Anli Chen, Arunan S Vamadevan, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 29, 2017
Myeloid ATG16L1 Facilitates Host-Bacteria Interactions in Maintaining Intestinal HomeostasisHong Zhang, Libo Zheng, Dermot P B McGovern, et al.
Inflammatory Bowel Diseases|June 16, 2011
Constitutive activation of epithelial TLR4 augments inflammatory responses to mucosal injury and drives colitis-associated tumorigenesisMasayuki Fukata, Limin Shang, Rebeca Santaolalla, et al.
Plos One|May 22, 2013
TLR4 activates the β-catenin pathway to cause intestinal neoplasiaRebeca Santaolalla, Daniel A Sussman, Jose R Ruiz, et al.
Pageof 5